document
contain
guidelin
treatment
bacteri
caus
felin
upper
respiratori
tract
diseas
urtd
canin
infecti
respiratori
diseas
complex
cirdc
previous
known
canin
infecti
tracheobronch
kennel
cough
complex
bronchiti
pneumonia
pyothorax
final
antimicrobi
guidelin
work
group
intern
societi
companion
anim
infecti
diseas
wwwiscaidorg
develop
guidelin
veterinari
recommend
antimicrobi
treatment
correspond
guidelin
human
medicin
evalu
consider
differ
among
speci
committe
unanim
believ
limit
object
publish
inform
relev
treatment
bacteri
respiratori
diseas
dog
cat
thu
work
group
use
modif
delhi
method
consensu
build
develop
guidelin
work
group
review
literatur
met
person
develop
initi
draft
guidelin
follow
number
revis
complet
electron
attempt
build
consensu
word
recommend
within
work
group
work
group
recommend
provid
guidelin
committe
member
ask
independ
select
whether
agre
neutral
disagre
recommend
updat
draft
document
complet
provid
expert
field
member
work
group
ask
rate
recommend
mean
system
recommend
receiv
disagre
vote
total
review
work
group
outsid
review
percentag
distribut
review
appropri
comment
present
guidelin
antimicrobi
use
guidelin
treatment
bacteri
respiratori
tract
infect
dog
cat
interpret
gener
recommend
reason
appropri
major
case
work
group
acknowledg
variabl
among
case
guidelin
consid
standard
care
must
follow
circumst
rather
consid
basi
decisionmak
potenti
differ
addit
approach
might
requir
case
although
guidelin
design
intern
guidelin
appropri
region
world
work
group
realiz
region
differ
antimicrobi
resist
rate
antimicrobi
avail
prescrib
pattern
restrict
use
agent
exist
user
document
oblig
familiar
local
region
regul
might
restrict
use
certain
antimicrobi
list
document
diagnost
treatment
recommend
contain
guidelin
larg
limit
relat
bacteri
infect
felin
upper
respiratori
tract
diseas
syndrom
consist
clinic
sign
includ
serou
mucopurul
ocular
nasal
discharg
epistaxi
sneez
conjunct
clinic
sign
acut
day
chronic
day
term
upper
respiratori
infect
uri
reserv
cat
clinic
sign
urtd
directli
associ
one
known
pathogen
viral
bacteri
fungal
organ
believ
major
cat
acut
clinic
sign
urtd
felin
herpesviru
caliciviru
fcv
associ
uri
cat
viral
infect
develop
secondari
bacteri
infect
staphylococcu
spp
streptococcu
spp
pasteurella
multocida
escherichia
coli
anaerob
organ
commonli
cultur
surfac
upper
respiratori
mucou
membran
healthi
cat
howev
sever
bacteri
speci
includ
chlamydia
feli
bordetella
bronchiseptica
streptococcu
cani
streptococcu
equi
subspp
zooepidemicu
mycoplasma
spp
isol
detect
molecular
techniqu
polymeras
chain
reaction
pcr
cat
urtd
without
presenc
pathogen
virus
suggest
primari
role
cat
presenc
purul
mucopurul
nasal
ocular
discharg
might
increas
suspicion
primari
secondari
bacteri
infect
present
definit
proof
associ
viral
fungal
agent
also
induc
mucopurul
discharg
cat
sign
urtd
day
durat
thorough
histori
evalu
particular
vaccin
statu
presenc
exposur
cat
whether
cat
allow
outdoor
contact
shelter
kennel
veterinari
hospit
health
statu
incontact
cat
health
statu
incontact
human
exposur
dog
might
board
recent
come
shelter
possibl
increas
risk
infect
b
bronchiseptica
likelihood
foreign
bodi
contact
includ
hous
plant
histori
recent
stress
thought
reactiv
infect
cat
care
ocular
oral
otic
examin
evalu
primari
problem
indic
thorac
auscult
perform
evalu
evid
concurr
lower
respiratori
diseas
work
group
recommend
cat
suspect
bacteri
uri
evalu
presenc
felin
leukemia
viru
antigen
felin
immunodefici
viru
antibodi
serum
accord
american
associ
felin
practition
retroviru
panel
report
although
retrovirus
caus
respiratori
diseas
directli
associ
lymphoma
could
caus
urtd
caus
immunosuppress
could
predispos
sever
viral
bacteri
uri
mani
diagnost
test
could
perform
assess
evid
primari
secondari
bacteri
uri
see
diagnosi
chronic
bacteri
upper
respiratori
infect
day
durat
section
opinion
work
group
limit
benefit
perform
cytolog
nasal
discharg
diagnos
bacteri
infect
guid
antimicrobi
choic
nasal
discharg
serou
lack
mucopurul
purul
compon
work
group
believ
antimicrobi
treatment
recommend
likelihood
uncompl
viral
infect
acut
bacteri
uri
suspect
base
purul
mucopurul
discharg
absenc
evid
caus
urtd
base
histori
physic
examin
find
work
group
recommend
period
observ
without
immedi
use
antimicrobi
drug
might
vari
durat
base
clinic
find
see
treatment
suspect
acut
bacteri
upper
respiratori
infect
section
human
antimicrobi
treatment
recommend
clinic
sign
improv
day
worsen
day
extens
workup
underli
caus
postpon
period
observ
day
onset
clinic
sign
cat
develop
chronic
urtd
aerob
bacteri
cultur
antimicrobi
suscept
test
result
nasal
discharg
difficult
interpret
pathogen
organ
eg
chlamydia
mycoplasma
cultur
standard
laboratori
media
posit
cultur
might
associ
bacteri
infect
due
growth
commens
organ
thu
work
group
recommend
aerob
bacteri
cultur
antimicrobi
suscept
test
perform
nasal
secret
collect
cat
acut
bacteri
uri
result
mycoplasma
spp
cultur
pcr
assay
molecular
diagnost
procedur
fcv
c
feli
difficult
interpret
individu
cat
mycoplasma
spp
fcv
c
feli
grown
amplifi
molecular
assay
healthi
diseas
cat
vaccin
strain
b
bronchiseptica
fcv
c
feli
detect
molecular
diagnost
assay
vari
period
time
depend
vaccin
type
posit
molecular
diagnost
test
fcv
c
feli
might
use
support
diagnosi
infect
presenc
suggest
clinic
sign
absenc
histori
recent
vaccin
howev
outbreak
uri
suspect
popul
cat
like
shelter
catteri
board
facil
multipl
cat
household
assay
also
might
indic
particularli
sever
clinic
diseas
occur
possibl
sever
affect
cat
evalu
increas
sensit
posit
predict
valu
assay
result
cat
mucopurul
nasal
discharg
maintain
normal
appetit
attitud
experi
spontan
resolut
ill
within
day
without
antimicrobi
treatment
work
group
recommend
antimicrobi
treatment
consid
within
observ
period
fever
lethargi
anorexia
present
concurr
mucopurul
nasal
discharg
antimicrobi
treatment
chosen
cat
acut
bacteri
uri
optim
durat
treatment
unknown
recommend
base
experi
work
group
member
clinician
work
group
recommend
empir
administr
doxycyclin
tabl
day
cat
suspect
acut
bacteri
uri
firstlin
antimicrobi
option
work
group
believ
doxycyclin
good
first
choic
well
toler
cat
b
bronchiseptica
isol
cat
suscept
doxycyclin
vitro
unapprov
standard
test
despit
resist
agent
betalactam
sulfonamid
doxycyclin
effect
vivo
treatment
cat
c
feli
infect
mycoplasma
spp
infect
doxycyclin
also
effect
treatment
varieti
chlamydi
mycoplasma
infect
cat
minocyclin
substitut
situat
doxycyclin
unavail
greater
expens
see
tabl
dose
recommend
b
cultur
antimicrobi
suscept
test
c
c
anim
clinic
find
lifethreaten
diseas
consensu
work
group
administ
dual
agent
treatment
parenter
potenti
deescal
treatment
switch
oral
drug
base
clinic
respons
cultur
antimicrobi
suscept
test
see
tabl
dose
differ
rout
text
recommend
oral
parenter
administr
enrofloxacin
often
chosen
veterinari
product
parenter
administr
drug
wide
spectrum
gramneg
organ
mycoplasma
spp
drug
wide
spectrum
gramneg
bacteria
substitut
base
antimicrobi
suscept
test
clinician
prefer
see
tabl
discuss
administ
enrofloxacin
drug
choic
enrofloxacin
administ
h
cat
lessen
risk
retin
degener
one
review
note
iv
ciprofloxacin
could
also
use
howev
review
believ
enrofloxacin
use
label
veterinari
use
e
enrofloxacin
drug
gramneg
activ
administ
parenter
anim
lifethreaten
diseas
concurr
administr
parenter
drug
activ
anaerob
gramposit
bacteria
recommend
common
choic
includ
ampicillin
clindamycin
drug
choos
depend
like
infecti
agent
suspect
histor
antimicrobi
resist
geograph
region
exampl
enterococcu
spp
streptococcu
spp
like
suscept
penicillin
toxoplasma
gondii
neospora
caninum
like
suscept
clindamycin
cephalosporin
gener
recommend
treatment
anaerob
infect
unpredict
activ
lack
evid
efficaci
pleas
see
text
discuss
potenti
drug
choic
combin
mammalian
host
speci
also
activ
mani
opportunist
bacteri
pathogen
compon
normal
microbiota
respiratori
tract
review
agre
work
group
recommend
disagre
breakpoint
data
antimicrobi
b
bronchiseptica
bacteria
cat
pharmacokinet
control
clinic
trial
suscept
data
pharmacodynam
data
base
recommend
due
delay
esophag
transit
time
capsul
tablet
cat
prone
druginduc
esophag
result
esophag
strictur
although
tabl
capsul
could
caus
problem
doxycyclin
hyclat
tablet
clindamycin
hydrochlorid
capsul
report
frequent
caus
problem
thu
tablet
capsul
given
coat
lubric
substanc
follow
water
administ
pill
treat
concurr
least
ml
liquid
follow
small
amount
food
doxycyclin
formul
approv
use
cat
avail
countri
use
avail
use
compound
suspens
doxycyclin
avoid
market
formul
violat
regul
countri
includ
usa
addit
compound
aqueousbas
formul
doxycyclin
associ
variabl
loss
activ
beyond
day
minocyclin
pharmacokinet
avail
cat
tetracyclin
evalu
efficaci
infecti
diseas
agent
cat
work
group
consid
amoxicillin
accept
altern
firstlin
option
treatment
acut
bacteri
uri
c
feli
mycoplasma
highli
suspect
base
evid
cat
administ
amoxicillin
treatment
suspect
secondari
bacteri
infect
shelter
cat
acut
bacteri
uri
often
appar
clinic
respons
cat
administ
amoxicillin
clavulan
potassium
amoxicillinclavulan
appar
clinic
respons
studi
shelter
cat
acut
bacteri
uri
drug
also
could
consid
altern
doxycyclin
region
high
preval
betalactamaseproduc
organ
identifi
eg
base
region
antibiogram
studi
shelter
cat
suspect
bacteri
uri
inject
cephalosporin
cefovecin
inferior
doxycyclin
amoxicillinclavulan
one
limit
studi
lack
neg
control
group
thu
opinion
work
group
evid
need
cefovecin
recommend
treatment
bacteri
uri
cat
tabl
cat
syndrom
rapidli
improv
within
day
without
antimicrobi
administr
antimicrobi
drug
prescrib
ineffect
bacteri
infect
still
suspect
first
day
administr
work
group
recommend
extens
diagnost
workup
offer
owner
altern
antimicrobi
agent
differ
spectrum
consid
owner
refus
diagnost
workup
care
reevalu
cat
still
support
presenc
bacteri
infect
without
obviou
underli
caus
see
diagnosi
acut
bacteri
upper
respiratori
infect
section
longer
durat
treatment
might
requir
clear
carrier
state
c
feli
diagnosi
chronic
bacteri
upper
respiratori
infect
day
durat
extens
diagnost
workup
consid
cat
urtd
day
durat
particularli
face
therapeut
failur
treatment
suspect
acut
bacteri
uri
describ
diagnost
workup
perform
evalu
caus
includ
cuterebra
spp
fungal
diseas
well
noninfecti
caus
urtd
includ
allerg
diseas
neoplasia
foreign
bodi
nasopharyng
stenosi
oronas
fistula
nasopharyng
polyp
trauma
referr
specialist
recommend
advanc
imag
rhinoscopi
capabl
avail
treatabl
caus
urtd
identifi
work
group
recommend
nasal
lavag
brush
cytolog
aerob
bacteri
cultur
antimicrobi
suscept
test
mycoplasma
spp
cultur
pcr
fungal
cultur
nasal
tissu
biopsi
histopatholog
examin
without
cultur
evalu
lavag
perform
review
agre
recommend
disagre
state
result
nasal
tissu
cultur
cat
chronic
urtd
alway
imposs
interpret
studi
nasal
lavag
specimen
gave
higher
sensit
bacteri
growth
tissu
biopsi
specimen
howev
discuss
previous
bacteri
cultur
result
difficult
imposs
interpret
bacteria
cultur
nasal
caviti
healthi
cat
exampl
multidrugresist
bacteria
colon
grown
nasal
passag
absenc
infect
purpos
cultur
suscept
test
cat
chronic
bacteri
uri
usual
identifi
antimicrobi
suscept
sever
secondari
bacteri
infect
occur
secondari
untreat
underli
caus
eg
idiopath
inflammatori
rhiniti
antimicrobi
treatment
cat
might
provid
relief
sever
clinic
sign
recogn
cat
continu
predispos
opportunist
infect
often
antimicrobialresist
bacteria
therefor
use
antimicrobi
limit
cat
sever
clinic
sign
work
group
recommend
consult
intern
medicin
specialist
expertis
infecti
diseas
clinic
pharmacologist
clinic
microbiologist
treat
multidrugresist
organ
resist
drug
class
isol
nasal
lavag
cultur
cat
chronic
bacteri
uri
antimicrobi
agent
select
basi
cultur
antimicrobi
suscept
test
result
avail
organ
resist
previous
prescrib
antimicrobi
agent
identifi
clinic
respons
poor
altern
drug
substitut
tabl
pradofloxacin
veterinari
fluoroquinolon
approv
countri
treatment
acut
infect
upper
respiratori
tract
caus
suscept
strain
p
multocida
e
coli
staphylococcu
intermediu
group
studi
shelter
cat
pradofloxacin
protocol
equival
amoxicillin
treatment
suspect
bacteri
uri
veterinari
fluoroquinolon
enrofloxacin
orbifloxacin
marbofloxacin
tabl
also
use
veterinarian
treat
suspect
felin
bacteri
uri
first
studi
cat
administ
antibiot
placebo
control
studi
evalu
pradofloxacin
treatment
bacteri
uri
cat
publish
knowledg
concern
emerg
anim
public
health
consequ
resist
fluoroquinolon
thirdgener
cephalosporin
work
group
recommend
drug
reserv
situat
cultur
suscept
result
indic
potenti
efficaci
antimicrobi
agent
eg
doxycyclin
amoxicillin
viabl
option
moreov
clinic
evid
indic
fluoroquinolon
thirdgener
cephalosporin
superior
doxycyclin
amoxicillin
treatment
chronic
bacteri
uri
cat
although
azithromycin
pharmacokinet
determin
cat
azithromycin
amoxicillin
protocol
treatment
suspect
bacteri
upper
respiratori
tract
infect
shelter
cat
equival
studi
cat
administ
antibiot
azithromycin
also
efficaci
doxycyclin
treatment
felin
ocular
chlamydiosi
studi
cat
administ
antibiot
thu
work
group
recommend
azithromycin
reserv
situat
chlamydiosi
like
antimicrobi
agent
eg
doxycyclin
amoxicillin
viabl
option
review
agre
recommend
one
review
comment
evid
azithromycin
treatment
peopl
produc
therapeut
benefit
infect
respiratori
tract
via
mechan
attribut
antibacteri
properti
howev
time
work
group
advoc
administr
azithromycin
anim
diseasemodifi
properti
immunomodulatori
effect
pseudomona
aeruginosa
isol
pure
nearli
pure
cultur
believ
caus
secondari
infect
extens
flush
nasal
caviti
anesthesia
perform
remov
locul
secret
although
use
drug
combin
fluoroquinolon
combin
betalactam
tabl
recommend
treat
p
aeruginosa
infect
tendenc
organ
rapidli
develop
resist
monotherapi
fluoroquinolon
accept
treatment
p
aeruginosa
otitisosteomyel
human
patient
unless
resist
encount
regardless
whether
monotherapi
combin
treatment
chosen
work
group
recommend
antimicrobi
select
basi
cultur
suscept
test
clinic
microbiologist
clinic
pharmacologist
intern
medicin
specialist
expertis
infecti
diseas
consult
initi
treatment
review
agre
recommend
neutral
optim
durat
treatment
chronic
bacteri
uri
cat
underli
diseas
unknown
consensu
work
group
administ
chosen
antimicrobi
least
day
drug
toler
show
posit
clinic
effect
drug
continu
long
progress
clinic
improv
least
week
past
clinic
resolut
nasal
diseas
plateau
respons
treatment
howev
work
group
acknowledg
stop
treatment
sooner
might
also
effect
cat
mucopurul
discharg
without
sneez
recur
treatment
cat
thorough
diagnost
evalu
previous
effect
antimicrobi
agent
usual
prescrib
empir
least
day
assess
treatment
respons
work
group
recommend
avoid
repeat
empir
treatment
regular
basi
whenev
possibl
howev
cat
suspect
chronic
bacteri
uri
requir
approach
lessen
clinic
sign
diseas
even
though
clinic
cure
never
achiev
work
group
believ
current
known
optim
protocol
repeat
empir
treatment
chronic
uri
cat
evid
human
infecti
diseas
literatur
show
organ
cultur
patient
within
month
primari
treatment
higher
likelihood
resist
treatment
drug
class
use
respiratori
treatment
guidelin
human
medicin
recommend
differ
drug
drug
class
use
within
month
initi
treatment
data
avail
work
group
recommend
use
previous
effect
antimicrobi
drug
switch
differ
drug
class
activ
drug
within
class
treatment
ineffect
minimum
hour
collect
specimen
cultur
suscept
recommend
neither
approach
success
evid
support
use
topic
intranas
antisept
antimicrobi
administr
treatment
acut
chronic
bacteri
uri
howev
topic
administr
salin
solut
believ
mild
mucolyt
effect
might
effect
clear
nasal
secret
cat
mani
cat
chronic
urtd
complet
diagnost
evalu
perform
find
lymphocyticplasmacyt
mix
inflamm
identifi
histopatholog
evalu
without
known
underli
caus
idiopath
felin
rhinosinus
although
chronic
infect
respiratori
virus
specul
play
role
diseas
true
underli
etiolog
remain
enigmat
although
associ
among
bartonella
spp
test
result
among
cat
without
urtd
shelter
studi
chronic
rhinosinus
anoth
studi
addit
research
requir
ascertain
role
bartonella
spp
felin
chronic
rhinosinus
result
bacteri
cultur
antimicrobi
suscept
test
specimen
collect
nasal
caviti
difficult
interpret
monitor
efficaci
treatment
cat
suspect
chronic
bacteri
uri
usual
base
clinic
sign
diseas
clinic
syndrom
associ
cirdc
gener
character
acut
onset
cough
without
sneez
nasal
ocular
discharg
also
occur
depend
infecti
agent
involv
fever
uncommon
might
present
virus
implic
includ
canin
adenoviru
canin
distemp
viru
canin
respiratori
coronaviru
canin
influenza
virus
canin
herpesviru
canin
pneumoviru
canin
parainfluenza
viru
bacteria
implic
primari
pathogen
complex
includ
b
bronchiseptica
equi
subspeci
zooepidemicu
mycoplasma
spp
dog
canin
distemp
viru
infect
often
diarrhea
mucopurul
ocular
nasal
discharg
might
confus
mucopurul
discharg
caus
primari
bacteri
pathogen
signific
health
dog
prognosi
possibl
underli
distemp
viru
infect
alway
consid
young
dog
mucopurul
ocular
nasal
discharg
even
sign
distemp
absent
infect
equi
subspeci
zooepidemicu
suspect
case
acut
hemorrhag
pneumonia
sudden
death
report
coinfect
multipl
respiratori
pathogen
common
dog
cirdc
agent
harbor
dog
clinic
sign
vaccin
avail
caus
cirdc
countri
includ
canin
parainfluenza
viru
canin
adenoviru
canin
distemp
viru
canin
influenza
viru
influenza
viru
b
bronchiseptica
except
canin
distemp
viru
immun
induc
vaccin
prevent
colon
shed
organ
clinic
sign
diseas
develop
vaccin
dog
aaha
canin
vaccin
guidelin
wwwaahanet
org
howev
morbid
gener
decreas
vaccin
compar
dog
vaccin
expos
pathogen
thorough
histori
physic
examin
perform
dog
suspect
cirdc
mani
diagnost
test
could
perform
assess
evid
primari
secondari
bacteri
cirdc
opinion
work
group
limit
benefit
perform
cytolog
nasal
discharg
diagnos
bacteri
infect
guid
antimicrobi
choic
aerob
bacteri
cultur
antimicrobi
suscept
test
mycoplasma
spp
cultur
pcr
assay
molecular
diagnost
procedur
canin
parainfluenza
viru
canin
adenoviru
canin
distemp
viru
canin
respiratori
coronaviru
canin
influenza
virus
canin
herpesviru
pneumoviru
b
bronchiseptica
mycoplasma
spp
cyno
alon
perform
howev
organ
grown
detect
molecular
method
healthi
diseas
dog
vaccin
strain
organ
amplifi
molecular
diagnost
assay
molecular
assay
might
also
limit
sensit
time
dog
present
examin
viral
shed
rate
tend
peak
earli
diseas
thu
test
gener
recommend
work
group
singl
case
typic
clinic
present
evid
pneumonia
highrisk
popul
eg
breed
kennel
involv
outbreak
cirdc
suspect
popul
dog
like
shelter
breed
kennel
board
facil
multipl
dog
household
molecular
assay
might
indic
along
bacteri
cultur
serolog
test
viral
pathogen
particularli
poor
respons
treatment
sever
clinic
diseas
occur
possibl
specimen
respiratori
discharg
collect
sever
affect
dog
assay
individu
increas
sensit
posit
predict
valu
necropsi
perform
fatal
clinic
sign
consist
pneumonia
develop
extens
diagnost
evalu
indic
see
pneumonia
dog
cat
section
major
case
cirdc
current
believ
viral
etiolog
antimicrobi
administr
often
indic
dog
clinic
sign
cirdc
includ
mucopurul
nasal
discharg
maintain
normal
appetit
attitud
might
resolv
spontan
within
day
without
antimicrobi
treatment
work
group
recommend
antimicrobi
treatment
consid
within
observ
period
fever
lethargi
inappet
present
togeth
mucopurul
discharg
bacteri
cirdc
suspect
dog
mucopurul
nasal
discharg
fever
lethargi
inappet
clinic
evid
pneumonia
eg
crackl
wheez
thorac
auscult
work
group
recommend
administr
doxycyclin
empir
day
firstlin
antimicrobi
option
tabl
doxycyclin
believ
clinic
activ
mycoplasma
cat
doxycyclin
well
toler
dog
isol
b
bronchiseptica
dog
typic
suscept
vitro
doxycyclin
howev
suscept
test
studi
use
unapprov
standard
optim
durat
treatment
dog
bacteri
caus
cirdc
unknown
recommend
base
clinic
experi
work
group
review
agre
recommend
disagre
one
review
state
evid
pneumonia
case
high
risk
pneumonia
brachycephal
collaps
airway
immunosuppress
antimicrobi
treatment
indic
dissent
review
disagre
recommend
breakpoint
data
doxycyclin
b
bronchiseptica
mycoplasma
spp
dog
whether
agent
truli
suscept
drug
unknown
addit
antimicrobi
suscept
data
secondari
bacteri
agent
like
pasteurella
spp
streptococcu
spp
staphylococcu
spp
anaerob
need
pasteurella
spp
streptococcu
spp
amoxicillin
usual
adequ
wherea
strain
staphylococcu
spp
usual
suscept
vitro
amoxicillinclavulan
acid
thu
antimicrobi
consid
work
group
altern
firstlin
antimicrobi
treatment
secondari
bacteri
infect
syndrom
treatment
doxycyclin
fail
possibl
eg
well
toler
howev
also
recogn
b
bronchiseptica
isol
mycoplasma
resist
amoxicillinclavulan
review
agre
review
disagre
review
neutral
review
provid
neg
comment
concern
concentr
betalactam
bronchial
secret
unknown
dog
cat
use
drug
could
ineffect
tracheobronch
without
pneumonia
present
anoth
concern
use
amoxicillinclavulan
like
select
resist
phenotyp
clinic
concern
eg
methicillin
resist
staphylococci
inhal
aminoglycosid
treatment
anecdot
mention
benefici
manag
dog
b
bronchisepticaassoci
cirdc
howev
absenc
control
studi
safeti
efficaci
work
group
recommend
treatment
protocol
dog
suspect
bacteri
cirdc
diseas
syndrom
usual
selflimit
respond
quickli
antimicrobi
treatment
thu
primari
repeat
diagnost
test
rare
need
unless
pneumonia
suspect
bacteri
cultur
recommend
success
treatment
canin
infecti
respiratori
diseas
complex
associ
chronic
upper
respiratori
diseas
dog
dog
bacteri
cirdc
clinic
sign
resolv
quickli
first
drug
chosen
ineffect
bacteri
diseas
still
suspect
first
day
work
group
recommend
extens
diagnost
workup
consid
consid
use
drug
class
like
fluoroquinolon
azithromycin
inflamm
bronchi
dog
cat
associ
mani
differ
condit
includ
inhal
irrit
infect
bacteria
virus
dirofilaria
immiti
respiratori
parasit
tissu
migrat
toxocara
cani
pharyng
esophag
dysfunct
allergi
acut
inflamm
bronchi
occur
secondari
primari
infecti
diseas
agent
discuss
acut
chronic
uri
cat
section
cirdc
section
gener
clinic
manifest
diagnost
plan
treatment
plan
describ
section
howev
dog
cat
infect
primari
bacteri
pathogen
b
bronchiseptica
mycoplasma
spp
develop
chronic
bronchiti
bronchopneumonia
addit
dog
cat
inflammatori
diseas
bronchi
anatom
defect
larynx
trachea
eg
laryng
paralysi
collaps
airway
might
develop
secondari
bacteri
bronchiti
sourc
bacteria
thought
natur
oral
microbiota
thu
bacteria
describ
secondari
bacteri
uri
cat
secondari
bacteri
cirdc
dog
might
associ
bronchiti
howev
mani
dog
chronic
bronchiti
larg
number
bacteria
cultur
bronchoalveolar
lavag
syndrom
alway
associ
bacteri
infect
primari
clinic
manifest
bacteri
bronchiti
dog
cat
cough
without
sign
respiratori
distress
dog
cat
chronic
cough
without
prior
evid
uri
cirdc
full
physic
examin
perform
includ
thorough
tracheal
thorac
auscult
thorac
radiograph
made
full
inspir
evalu
pulmonari
cardiac
chang
could
associ
cough
dog
radiograph
includ
cervic
intrathorac
trachea
inspiratori
expiratori
radiograph
perform
identifi
collaps
airway
altern
fluoroscopi
avail
veterinari
clinic
diagnosi
collaps
airway
dog
cat
bacteri
bronchiti
radiograph
evid
thicken
bronchi
other
normal
radiograph
even
though
inflamm
exist
cytolog
airway
wash
comput
tomographi
also
use
determin
extent
diseas
caus
bronchial
inflamm
explor
immiti
serolog
fecal
flotat
fecal
sediment
baermann
test
laryng
function
evalu
indic
histori
radiograph
evid
bronchial
diseas
present
suspect
base
clinic
find
airway
wash
cytolog
examin
indic
determin
type
inflamm
present
obtain
materi
mycoplasma
spp
cultur
aerob
bacteri
cultur
antimicrobi
suscept
test
mycoplasma
pcr
assay
result
alway
correl
cultur
might
reflect
oral
contamin
specimen
obtain
bronchoscopi
accur
diagnosi
collect
specimen
method
like
tracheal
wash
accept
diffus
diseas
present
bronchoscopi
avail
afford
great
risk
anim
result
analysi
bronchoalveolar
lavag
brush
specimen
alway
agreement
presenc
neutrophil
inflamm
intracellular
bacteria
posit
bacteri
cultur
characterist
radiograph
find
suggest
primari
secondari
bacteri
bronchiti
howev
trachea
steril
normal
dog
low
number
bacteria
cultur
absenc
cytolog
evid
intracellular
bacteria
might
impli
bacteri
infect
wait
result
cultur
antimicrobi
suscept
test
work
group
recommend
either
antimicrobi
treatment
clinic
diseas
sever
empir
administr
doxycyclin
day
tabl
use
doxycyclin
recommend
base
vitro
activ
b
bronchiseptica
isol
dog
cat
report
posit
clinic
respons
doxycyclin
cat
respiratori
mycoplasma
infect
low
rate
advers
effect
review
agre
work
group
recommend
disagre
breakpoint
data
antimicrobi
drug
bacteria
dog
depend
clinic
laboratori
test
result
antimicrobi
treatment
continu
initi
modifi
base
antimicrobi
suscept
test
drug
select
one
believ
penetr
blood
bronchu
barrier
base
data
speci
posit
respons
obtain
first
day
treatment
continu
week
past
resolut
clinic
sign
diseas
optim
durat
treatment
syndrom
unknown
recommend
base
experi
clinician
work
group
dog
fail
respond
antimicrobi
treatment
like
primari
chronic
noninfecti
bronchiti
veterinari
microbiolog
laboratori
report
antimicrobi
suscept
result
mycoplasma
spp
genu
difficult
cultur
thu
antimicrobi
choic
dog
suspect
proven
mycoplasmaassoci
bronchiti
often
made
empir
doxycyclin
minocyclin
commonli
use
veterinarian
syndrom
like
therapeut
effect
pet
suspect
mycoplasma
spp
bronchiti
veterinari
fluoroquinolon
azithromycin
drug
might
effect
treatment
mycoplasma
spp
infect
bronchiti
associ
mycoplasma
spp
b
bronchiseptica
clinic
resolut
might
obtain
cours
antimicrobi
treatment
case
prolong
antimicrobi
treatment
might
need
event
anoth
primari
caus
inflamm
allerg
bronchiti
exist
secondari
bacteri
infect
occur
recurr
treatment
might
requir
control
inflamm
associ
primari
diseas
syndrom
might
also
lessen
recurr
secondari
bacteri
bronchiti
repeat
thorac
radiograph
taken
follow
bronchial
chang
limit
sensit
case
repeat
cytolog
cultur
might
indic
inflamm
lung
pneumonia
occur
varieti
insult
dog
cat
although
uncommon
primari
bacteri
pneumonia
occur
infect
b
bronchiseptica
mycoplasma
spp
equi
zooepidemicu
cani
yersinia
pesti
puppi
year
age
commun
acquir
pneumonia
unit
state
infect
b
bronchiseptica
dog
b
bronchiseptica
infect
younger
sever
diseas
dog
bacteria
cultur
case
bacteri
pneumonia
dog
cat
secondari
primari
inflammatori
event
like
viral
infect
aspir
oral
esophag
gastric
content
vomit
regurgit
commonli
associ
megaesophagu
aspir
pharyng
laryng
function
abnorm
anesthesia
recoveri
inhal
foreign
bodi
addit
bacteri
pneumonia
develop
presenc
immunodefici
syndrom
secondari
bacteri
pneumonia
potenti
could
develop
result
pulmonari
airway
diseas
like
neoplasia
ciliari
dyskinesia
bronchiectasi
collaps
airway
common
organ
isol
dog
cat
lower
respiratori
diseas
includ
e
coli
pasteurella
spp
streptococcu
spp
b
bronchiseptica
enterococcu
spp
mycoplasma
spp
pseudintermediu
coagulaseposit
staphylococcu
spp
pseudomona
spp
dog
cat
develop
cough
associ
fever
lethargi
inappet
tachypnea
evalu
presenc
pneumonia
full
physic
examin
complet
blood
cell
count
thorac
radiograph
clinicopatholog
find
thorac
radiolog
find
alveolar
lung
diseas
support
diagnosi
bacteri
pneumonia
collect
transtrach
endotrach
bronchoalveolar
lavag
specimen
cytolog
examin
aerob
bacteri
cultur
antimicrobi
suscept
mycoplasma
spp
cultur
recommend
cultur
suscept
test
recommend
client
perform
start
antimicrobi
drug
treatment
provid
anim
suffici
stabl
howev
antimicrobi
treatment
unduli
delay
although
control
data
avail
dog
cat
clinic
opinion
work
group
antimicrobi
treatment
initi
soon
possibl
within
hour
clinic
sign
sepsi
exist
addit
case
aspir
pneumonia
requir
antimicrobi
treatment
clinic
diseas
might
primarili
sole
chemic
pneumon
aspir
materi
anaerob
bacteria
sometim
associ
pneumonia
particularli
histori
aspir
grass
awn
foreign
bodi
present
howev
commerci
laboratori
difficulti
cultur
agent
provid
antimicrobi
suscept
data
thu
antimicrobi
agent
anaerob
spectrum
often
includ
treatment
bacteri
pneumonia
dog
cat
anaerob
cultur
avail
like
reliabl
case
probabl
aspir
pneumonia
multipl
bacteria
often
cultur
make
difficult
determin
involv
continu
inflamm
care
also
exercis
interpret
signific
rare
organ
mix
cultur
presenc
possibl
airway
contamin
coagulaseneg
staphylococci
bacillu
spp
endoscop
use
collect
lavag
specimen
possibl
endoscoperel
contamin
also
consid
particularli
unusu
speci
serratia
stenotrophomona
isol
work
group
recommend
consult
clinic
microbiologist
specialist
expertis
infecti
diseas
pulmonolog
interpret
cultur
antimicrobi
suscept
result
endotrach
bronchoalveolar
lavag
specimen
fifteen
review
agre
disagre
neutral
work
group
recommend
person
disagre
believ
consult
need
difficult
case
bacteri
pneumonia
often
associ
underli
diseas
process
attempt
identifi
manag
current
problem
made
cat
dog
lifethreaten
bacteri
pneumonia
oxygen
depend
airway
sampl
might
feasibl
although
data
requir
clarifi
use
blood
cultur
aerob
anaerob
anim
sever
pneumonia
consensu
opinion
work
group
consid
blood
cultur
anim
start
empir
antimicrobi
drug
treatment
altern
way
obtain
isol
target
antimicrobi
suscept
guid
longterm
manag
empir
antimicrobi
treatment
delay
effort
stabil
affect
anim
obtain
preantimicrobi
airway
sampl
thirteen
review
agre
neutral
disagre
work
group
recommend
primari
comment
blood
cultur
purpos
children
known
insensit
falseposit
result
obtain
work
group
discuss
whether
antimicrobi
treatment
delay
wait
result
cultur
antimicrobi
suscept
test
avail
howev
client
afford
diagnost
procedur
pneumonia
lifethreaten
diseas
consensu
opinion
provid
empir
antimicrobi
treatment
wait
test
result
potenti
deescal
treatment
base
antimicrobi
suscept
test
hospit
parenter
antimicrobi
treatment
gener
recommend
work
group
treatment
anim
pneumonia
regardless
sever
diseas
anim
discharg
treatment
continu
mean
oral
rout
opinion
work
group
doxycyclin
reason
empir
choic
dog
cat
mild
pneumonia
suspect
infect
b
bronchiseptica
mycoplasma
spp
eg
anim
shelter
board
environ
system
sign
diseas
like
fever
dehydr
lethargi
respiratori
distress
present
base
known
suscept
organ
doxycyclin
see
section
canin
infecti
respiratori
diseas
complex
publish
case
report
success
treatment
doxycyclin
tabl
fifteen
review
agre
disagre
work
group
recommend
one
review
state
doubt
pneumonia
would
present
without
fever
pneumonia
exist
treat
bactericid
drug
dissent
review
comment
lack
breakpoint
data
doxycyclin
bacteria
dog
cat
well
concern
doxycyclin
might
penetr
extracellular
fluid
lung
azithromycin
use
veterinarian
empir
dog
uncompl
pneumonia
work
group
believ
data
support
recommend
lack
streptococcu
equi
subspeci
zooepidemicu
strain
isol
dog
suscept
penicillin
amoxicillin
ampicillin
administr
amoxicillinclavulan
unnecessari
organ
suspect
streptococci
known
produc
betalactamas
dog
cat
acut
aspir
pneumonia
bacteri
infect
howev
aspir
bacteria
caus
infect
secondari
chemic
inflamm
associ
aspir
dog
cat
acut
affect
evid
system
sepsi
work
group
believ
either
treatment
parenter
administr
betalactam
antimicrobi
like
ampicillin
ampicillinsulbactam
firstgener
cephalosporin
cefazolin
might
suffici
tabl
thirteen
review
agre
neutral
disagre
work
group
recommend
primari
comment
risk
treat
case
greater
perceiv
benefit
withhold
treatment
oral
medic
could
adequ
syndrom
howev
megaesophagu
esophag
motil
disord
exist
parenter
administr
antimicrobi
drug
indic
clinic
find
dog
cat
pneumonia
suggest
exist
sepsi
eg
inject
mucou
membran
hypoglycemia
work
group
recommend
concurr
parenter
administr
either
enrofloxacin
marbofloxacin
avail
inject
form
countri
combin
drug
gramposit
anaerob
spectra
bacteri
cultur
antimicrobi
suscept
test
result
return
studi
bacteria
lower
airway
dog
respiratori
diseas
suscept
enrofloxacin
drug
parenter
use
gramneg
spectrum
might
indic
lieu
enrofloxacin
base
cultur
antimicrobi
suscept
test
tabl
work
group
state
common
option
gramposit
anaerob
bacteria
includ
ampicillin
clindamycin
administ
parenter
tabl
drug
choos
wait
antimicrobi
suscept
test
result
depend
like
infecti
agent
suspect
previous
prescrib
antimicrobi
histor
antimicrobi
resist
geograph
region
fourteen
review
agre
disagre
work
group
recommend
primari
comment
bacteroid
spp
present
clindamycin
could
ineffect
metronidazol
could
consid
anoth
option
drug
could
administ
po
outpati
treatment
bacteri
pneumonia
select
basi
cultur
antimicrobi
suscept
result
organ
isol
lower
airway
deescal
whenev
possibl
cultur
antimicrobi
suscept
test
perform
antimicrobi
drug
class
class
initi
prescrib
associ
clinic
respons
isar
chosen
continu
oral
treatment
inflammatori
respons
bacteri
pneumonia
increas
pulmonari
patholog
thu
glucocorticoid
use
concurr
human
patient
bacteri
pneumonia
howev
consensu
opinion
work
group
data
need
dog
cat
definit
recommend
made
regard
use
system
inhal
glucocorticoid
potenti
contribut
advers
outcom
due
immunosuppress
current
recommend
veterinari
textbook
treat
bacteri
pneumonia
week
evid
support
durat
treatment
either
cat
dog
lack
although
lengthi
cours
antimicrobi
treatment
might
necessari
anim
sever
pulmonari
involv
immunodefici
syndrom
consensu
opinion
work
group
shorter
cours
appropri
treatment
use
treat
pneumonia
human
might
effect
situat
face
insuffici
data
support
shorter
cours
treatment
work
group
recommend
reevalu
anim
pneumonia
later
day
start
treatment
point
decis
extend
treatment
base
clinic
hematolog
radiograph
find
addit
studi
evalu
durat
treatment
shorter
week
requir
cat
pyothorax
bacteria
isol
thorac
fluid
commonli
mixtur
oropharyng
anaerob
includ
fusobacterium
prevotella
porphyromona
bacteroid
peptostreptococcu
clostridium
actinomyc
filifactor
villosu
pasteurella
spp
streptococcu
spp
mycoplasma
spp
also
isol
less
commonli
staphylococcu
spp
gramneg
bacteria
pasteurella
organ
nocardia
spp
rhodococcu
equi
isol
wound
result
cat
fight
uri
risk
factor
pyothorax
cat
bacteria
isol
dog
pyothorax
commonli
mix
anaerob
prevotella
spp
peptostreptococcu
spp
propionibacterium
acn
clostridium
spp
bacteroid
spp
fusobacterium
spp
enterobacteriacea
especi
e
coli
klebsiella
pneumonia
streptococcu
cani
staphylococcu
spp
enterococcu
spp
corynebacterium
spp
bacillu
spp
trueperella
formerli
arcanobacterium
pyogen
pasteurella
acinetobact
capnocytophaga
spp
enterobact
spp
stenotrophomona
maltophila
aeromona
hydrophila
achromobact
xylosoxidan
serratia
marcescen
pseudomona
spp
actinomyc
spp
lesser
extent
nocardia
spp
streptomyc
spp
implic
canin
pyothorax
pyothorax
dog
commonli
result
migrat
plant
foreign
bodi
trauma
also
result
bite
wound
inocul
thorac
radiograph
made
evalu
presenc
lung
consolid
dog
cat
therapeut
thoracocentesi
pleural
fluid
specimen
submit
cytolog
analysi
aerob
bacteri
cultur
antimicrobi
suscept
test
well
cultur
anaerob
bacteria
mycoplasma
spp
cat
avail
perform
gram
stain
acidfast
stain
might
provid
addit
inform
detect
actinomycet
mycoplasma
spp
requir
special
growth
condit
prolong
incub
laboratori
inform
actinomyc
spp
nocardia
spp
mycoplasma
spp
differenti
diagnos
work
group
recommend
treatment
pyothorax
includ
iv
fluid
administr
critic
drainag
pu
placement
chest
tube
intermitt
prefer
continu
suction
without
lavag
surgic
debrid
might
requir
case
sixteen
review
agre
disagre
work
group
recommend
primari
comment
evid
support
definit
need
thorac
lavag
lack
howev
base
lack
data
support
use
work
group
recommend
administr
antimicrobi
drug
pleural
space
work
group
recommend
combin
parenter
administr
enrofloxacin
marbofloxacin
avail
parenter
form
penicillin
clindamycin
combin
therapeut
drainag
pleural
space
without
lavag
initi
treatment
canin
felin
pyothorax
pend
result
cultur
antimicrobi
suscept
test
sixteen
review
agre
disagre
work
group
recommend
primari
comment
pradofloxacin
administ
po
singl
drug
could
effect
avail
treatment
antimicrobi
drug
activ
anaerob
continu
regardless
cultur
result
fastidi
anaerob
bacteria
could
present
combin
treatment
initi
bacteri
isol
suscept
drug
initi
treatment
regim
either
treatment
drug
could
discontinu
organ
grown
resist
one
drug
clinic
improv
note
antimicrobi
agent
discontinu
second
drug
isol
suscept
substitut
anim
respond
suffici
organ
grown
resist
antimicrobi
clinic
evid
improv
evid
antimicrobi
treatment
chang
drug
organ
suscept
vitro
fifteen
review
agre
neutral
disagre
work
group
recommend
dissent
review
state
mix
cultur
result
difficult
interpret
anim
clinic
condit
improv
first
therapeut
regimen
chang
made
consult
specialist
recommend
multidrugresist
organ
isol
situat
clinic
condit
must
consid
interpret
cultur
result
continu
appar
effect
treatment
despit
vitro
resist
recommend
potenti
offend
organ
isol
recommend
cat
pyothorax
treat
minimum
week
ideal
week
addit
research
requir
determin
whether
shorter
period
antimicrobi
drug
treatment
might
adequ
serial
thorac
radiographi
might
use
determin
whether
antimicrobi
treatment
need
continu
although
studi
also
requir
determin
whether
persist
radiograph
abnorm
correl
need
addit
antimicrobi
drug
treatment
minimum
followup
radiographi
perform
day
start
treatment
complet
treatment
pyothorax
persist
reoccur
cessat
antimicrobi
repeat
thoracocentesi
perform
cytolog
assess
cultur
antimicrobi
suscept
test
work
group
emphas
need
addit
prospect
studi
evalu
differ
treatment
treatment
durat
dog
cat
bacteri
respiratori
diseas
accur
recommend
made
purpos
research
need
develop
standard
practic
collect
clinic
specimen
interpret
cultur
result
work
group
thank
follow
individu
prepubl
review
document
provid
vote
use
panel
recommenda
grant
support
work
support
intern
societi
companion
anim
infecti
diseas
iscaid
wwwiscaidorg
conflict
interest
declar
jane
syke
serv
associ
editor
journal
veterinari
intern
medicin
involv
review
manuscript
mg
papich
receiv
consult
fee
research
support
gift
bayer
zoeti
sponsor
antibiot
recommend
manuscript
receiv
royalti
book
publish
elsevi
sourc
dosag
list
paper
offlabel
antimicrobi
declar
document
describ
offlabel
antimicrobi
use
multipl
section
